Bishnoi, Harish Kumar <br/><br/>
The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.  [electronic resource] 

 -  Pharmacological research  Oct 2012 
 - 349-56 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1096-1186 
<br/><br/><label>Standard No.: </label>10.1016/j.phrs.2012.07.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Animals<br/>Benzimidazoles--pharmacology<br/>Benzoates--pharmacology<br/>Blood Glucose--metabolism<br/>Creatine--blood<br/>Diabetes Mellitus--chemically induced<br/>Diabetic Nephropathies--blood<br/>Drug Therapy, Combination<br/>Female<br/>Fenofibrate--pharmacology<br/>Hypolipidemic Agents--pharmacology<br/>Kidney--drug effects<br/>Lipids--blood<br/>Male<br/>Nitrogen--blood<br/>Oxidative Stress--drug effects<br/>PPAR alpha--agonists<br/>Proteinuria--prevention & control<br/>Rats<br/>Rats, Wistar<br/>Streptozocin<br/>Telmisartan